Studying Cancer as an Adverse Outcome from Nononcological Therapies
Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract
Midkiff, K., Harris, D., Gilsenan, A., & Andrews, E. (2015). Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract. Pharmacoepidemiology and Drug Safety, 24(S1), 448-449. https://doi.org/10.1002/pds.3838
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.